Stay updated with breaking news from Cgi Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.
Maharashtra based pharmaceutical company has the highest market share in low dose atropine -- MYATRO 0.01 per cent eye drops -- is used to treat eye problems like myopia, especially in children.
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.
The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult patients with Covid-19 and who have high risk of progression of the disease.
According to the data shared by the Union Health Ministry on Friday, the country saw a total of 35,743 discharges in the last 24 hours.